Small molecule · Inhibitor of bacterial 30S ribosomal subunit · developed by Chartwell Rx
ApprovedFDA, Dec 1989
1Registered trials
What is Doxycycline?
Doxycycline is a tetracycline-class antibiotic that reversibly binds the bacterial 30S ribosomal subunit and inhibits bacterial protein synthesis. An extended-release formulation (D-PLEX) is studied for preventing surgical site infections.
Summary written with AI from the sources listed at the end of this page.
Approved as Doxycycline Monohydrate (December 29, 1989), NDA050641 · FDA label
✅ FDA-approved uses
Inflammatory lesions of rosacea
Rocky Mountain spotted fever
Typhus fever and typhus group
Q fever
Rickettsialpox
Tick fevers
Respiratory tract infections caused by Mycoplasma pneumoniae
Lymphogranuloma venereum
From the indications section of the FDA label (version of Apr 15, 2025). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.